[go: up one dir, main page]

AU6924698A - Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product - Google Patents

Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product

Info

Publication number
AU6924698A
AU6924698A AU69246/98A AU6924698A AU6924698A AU 6924698 A AU6924698 A AU 6924698A AU 69246/98 A AU69246/98 A AU 69246/98A AU 6924698 A AU6924698 A AU 6924698A AU 6924698 A AU6924698 A AU 6924698A
Authority
AU
Australia
Prior art keywords
cosmetic
pharmaceutical product
extract
irvingia gabonensis
irvingia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69246/98A
Inventor
Gilles Pauly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Health and Care Products France SAS
Original Assignee
Laboratoires Serobiologiques SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serobiologiques SA filed Critical Laboratoires Serobiologiques SA
Publication of AU6924698A publication Critical patent/AU6924698A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The use of at least an Irvingia gabonensis extract, in particular Irvingia gabonensis seeds, as active agent(s) for preparing a cosmetic and/or pharmaceutical product for topical use on the skin and/or superficial body growth, the extract being present between 0.05% and 50.00% by weight.
AU69246/98A 1997-04-14 1998-03-17 Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product Abandoned AU6924698A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9704732 1997-04-14
FR9704732A FR2761885B1 (en) 1997-04-14 1997-04-14 USE OF AT LEAST ONE IRVINGIA GABONENSIS EXTRACT IN A COSMETIC AND / OR PHARMACEUTICAL PRODUCT
PCT/FR1998/000538 WO1998046204A1 (en) 1997-04-14 1998-03-17 Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product

Publications (1)

Publication Number Publication Date
AU6924698A true AU6924698A (en) 1998-11-11

Family

ID=9506021

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69246/98A Abandoned AU6924698A (en) 1997-04-14 1998-03-17 Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product

Country Status (11)

Country Link
US (1) US6216707B1 (en)
EP (1) EP0977550B1 (en)
JP (1) JP2001518909A (en)
KR (1) KR100564824B1 (en)
AT (1) ATE303127T1 (en)
AU (1) AU6924698A (en)
CA (1) CA2288284A1 (en)
DE (1) DE69831404T2 (en)
ES (1) ES2248895T3 (en)
FR (1) FR2761885B1 (en)
WO (1) WO1998046204A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814063B1 (en) * 2000-09-15 2002-11-29 Clarins Lab COSMETIC COMPOSITION FOR LIPS CARE
US20060263450A1 (en) * 2005-05-17 2006-11-23 Julius Oben Method and composition for reducing body weight and improving control of body lipids
US7726320B2 (en) 2006-10-18 2010-06-01 R. J. Reynolds Tobacco Company Tobacco-containing smoking article
US20100098793A1 (en) * 2008-10-17 2010-04-22 Gateway Health Alliances, Inc. Irvingia gabonensis to treat and prevent metabolic syndrome and reduce total cholesterol, ldl cholesterol, blood glucose, c-reactive protein, and leptin levels and increasing adiponectin levels
US20100098792A1 (en) * 2008-10-17 2010-04-22 Gateway Health Alliances, Inc. Methods and compositions using irvingia gabonensis to reduce weight, control obesity, effect adipogenesis, lower ppar-gamma, leptin, g3pdh and triglycerides levels and increase adiponectin levels
US20120125354A1 (en) 2010-11-18 2012-05-24 R.J. Reynolds Tobacco Company Fire-Cured Tobacco Extract and Tobacco Products Made Therefrom
WO2013142483A1 (en) 2012-03-19 2013-09-26 R. J. Reynolds Tobacco Company Method for treating an extracted tobacco pulp and tobacco products made therefrom
US11019850B2 (en) 2018-02-26 2021-06-01 Rai Strategic Holdings, Inc. Heat conducting substrate for electrically heated aerosol delivery device
US11753750B2 (en) 2018-11-20 2023-09-12 R.J. Reynolds Tobacco Company Conductive aerosol generating composite substrate for aerosol source member
US11324249B2 (en) 2019-03-06 2022-05-10 R.J. Reynolds Tobacco Company Aerosol delivery device with nanocellulose substrate
US12022859B2 (en) 2019-07-18 2024-07-02 R.J. Reynolds Tobacco Company Thermal energy absorbers for tobacco heating products
US20210195938A1 (en) 2019-12-27 2021-07-01 Nicoventures Trading Limited Substrate with multiple aerosol forming materials for aerosol delivery device
US12484610B2 (en) 2020-04-16 2025-12-02 R.J. Reynolds Tobacco Company Aerosol delivery device including a segregated substrate
US11771132B2 (en) 2020-08-27 2023-10-03 Rai Strategic Holdings, Inc. Atomization nozzle for aerosol delivery device
US11771136B2 (en) 2020-09-28 2023-10-03 Rai Strategic Holdings, Inc. Aerosol delivery device
CN119947602A (en) 2021-06-30 2025-05-06 尼科凡图尔斯贸易有限公司 Substrates with multiple aerosol-forming materials for aerosol delivery devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964500A (en) * 1973-12-26 1976-06-22 Lever Brothers Company Lusterizing shampoo containing a polysiloxane and a hair-bodying agent
DE4405127A1 (en) * 1994-02-18 1995-08-31 Henkel Kgaa Hair treatment products
FR2723311B1 (en) * 1994-08-02 1996-10-25 Oreal PROCESS FOR TREATING HUMAN KERATINIC FIBERS USING FATTY CHAIN AMIDES AND WATER VAPOR
TW527191B (en) * 1997-07-09 2003-04-11 Kao Corp Hair treatment composition

Also Published As

Publication number Publication date
WO1998046204A1 (en) 1998-10-22
DE69831404D1 (en) 2005-10-06
KR100564824B1 (en) 2006-03-30
FR2761885A1 (en) 1998-10-16
EP0977550A1 (en) 2000-02-09
US6216707B1 (en) 2001-04-17
EP0977550B1 (en) 2005-08-31
ATE303127T1 (en) 2005-09-15
FR2761885B1 (en) 1999-06-04
JP2001518909A (en) 2001-10-16
DE69831404T2 (en) 2006-07-27
CA2288284A1 (en) 1998-10-22
KR20010006337A (en) 2001-01-26
ES2248895T3 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
AU6924698A (en) Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
CA2169087A1 (en) Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
SG64325A1 (en) Thermoplastic elasomeric copolymers and hair and skin care compositions containing the same
GR3033501T3 (en) Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
HU9503860D0 (en) Thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
AU3364001A (en) Method for tabletting thickening systems
CA2311696A1 (en) Self-tanning composition comprising carmine
PL302979A1 (en) Pharmaceutical and/or cosmetic preparation and application thereof
AU8170994A (en) Phospholipids as a vector for an active molecule, their preparation and their use in cosmetic or dermatological compositions
AU6564794A (en) Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
AU4775099A (en) Trichological lotion for topical use
UA35611C2 (en) Topical composition for inhibiting hair growth in mammals, method for application and topical composition for delivering water-soluble pharmaceutical to skin
CA2207783A1 (en) Antiperspirant or deodorant composition comprising a moisturizing cream
CA2124531A1 (en) Retinoid composition
MXPA03010429A (en) Topical product with visual indicator.
CA2265791A1 (en) External preparations containing watercress extract
AU3946197A (en) Cosmetic, dermatological and pharmaceutical use of a terminalia catappa extract
ES2137125A1 (en) Use of the zinc salt of glycyrrhetic acid in preparations against acne, and the compositions which contain said salt.
AU7029298A (en) Cosmetic body-care preparation and process for preparing the same
CA2279962A1 (en) An anhydrous antiperspirant composition comprising a pentane propellant
AU5487101A (en) Cosmetic or dermatological product comprising a freeze-dried hydrocolloid composition
AU7076494A (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
WO1991013606A3 (en) Use of 3,7-dimethyloctan-1-ol in cosmetic and dermatological preparations
AU4318397A (en) Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period